
Gay and bisexual men in San Francisco are signing up to take Gardasil, the vaccine intended to prevent the human papillomavirus in women. Men are asking their doctors for the vaccine, hoping it will prevent anal and penile cancer, which can also be caused by HPV, Jason Riggs, spokesman for the STOP AIDS Project, told KPIX in San Francisco.
"The prevalence of anal cancer among gay and bisexual men is very high," Riggs said in the report. "So that's why some people are looking at this as a possible preventive cure for anal cancer and HPV that causes anal cancer."
According to KPIX, anal cancer occurs among gay and bisexual men at a rate 35 times higher than that of the general population, occurring more in those infected with HIV.
However, concerns have been raised over the validity of men taking the drug, since it is not yet clear whether the drug is as effective for men as it is for women. (The Advocate)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
Comments that do not concern specific articles in The Advocate or on Advocate.com will not be posted or published. See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.